
G-G Vin500 mg
Gonoshasthaya Pharmaceuticals Limited
Approved / Established Uses Griseofulvin [Microsize] is an oral antifungal agent indicated for the treatment of dermatophyte (ringworm) infections of the skin, hair and more.
Griseofulvin [Microsize] is an oral antifungal agent indicated for the treatment of dermatophyte (ringworm) infections of the skin, hair, and nails caused by susceptible species of Trichophyton, Microsporum, and Epidermophyton, when the infection is extensive, chronic, or otherwise inadequately responsive to topical antifungal therapy alone. Established indications include:
Griseofulvin [Microsize] has no activity against bacteria, yeasts (including Candida), or other fungi outside the dermatophyte group, and should not be used for these infections.
The dose and duration of Griseofulvin [Microsize] depend on the site and severity of the infection. Treatment must be continued until the infected tissue is completely replaced by healthy, fungus-free tissue — stopping early, even if symptoms improve, risks relapse.
| Indication | Typical Adult Dose (microsize) | Typical Duration |
|---|---|---|
| Tinea corporis, tinea cruris | 500 mg/day, in single or divided doses | 2–4 weeks |
| Tinea capitis | 500 mg/day (higher doses may be used per physician judgment) | 4–8 weeks or longer |
| Tinea pedis, tinea manuum | 0.75–1 g/day, in divided doses | 4–8 weeks |
| Onychomycosis (fingernails) | 0.75–1 g/day | At least 4 months |
| Onychomycosis (toenails) | 0.75–1 g/day | At least 6 months, often longer |
Weight-based dosing is used in children old enough to be treated (see Use in Special Populations and Pediatric Uses).
Take Griseofulvin [Microsize] exactly as prescribed by your physician; do not stop, extend, skip doses, or share this medicine with others without medical advice, as inadequate treatment duration increases the risk of relapse and treatment failure.
The most common side effect of Griseofulvin [Microsize] is headache, which occurs frequently, especially early in treatment, and often diminishes with continued use.
Griseofulvin [Microsize] is contraindicated in patients with:
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.